INmune Bio director James Sapirstein files initial beneficial ownership statement
INMB•Form 3 filing names James Sapirstein as director
- INmune Bio filed a Form 3 naming James Sapirstein as a director in an initial statement of beneficial ownership dated Sept. 8, 2026.
